有效SARS-CoV-2疫苗的佐剂选择

Ling Xue, Jiao Li, Lin Wei, Cuiqing Ma, Suiyi Tan
{"title":"有效SARS-CoV-2疫苗的佐剂选择","authors":"Ling Xue, Jiao Li, Lin Wei, Cuiqing Ma, Suiyi Tan","doi":"10.35248/2379-1764.20.8.274","DOIUrl":null,"url":null,"abstract":"Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2 infection, has spread all over the world as an emerging infectious disease, causing a very serious impact on the global economy and public health. To date, there is no specific treatment or vaccines against coronaviruses. To prevent the infection and stop the pandemic, the research and development of effective SARS-CoV-2 vaccines has become an urgent matter. It is worth mentioning that appropriate adjuvants could enhance the strength and speed of the immune responses to vaccination. However, it takes time to customize different adjuvants with distinct targets (cellular or humoral immunity) and action intensity according to different antigens. In this review, we summarize the mechanism, advantages and disadvantages of adjuvants commonly used in licensed vaccines, as well as some novel adjuvants under development, hoping to provide information and increase the chances of success in developing effective SARS-CoV-2 vaccines in a short time frame.","PeriodicalId":7277,"journal":{"name":"Advanced techniques in biology & medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adjuvant Option for Effective SARS-CoV-2 Vaccine\",\"authors\":\"Ling Xue, Jiao Li, Lin Wei, Cuiqing Ma, Suiyi Tan\",\"doi\":\"10.35248/2379-1764.20.8.274\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2 infection, has spread all over the world as an emerging infectious disease, causing a very serious impact on the global economy and public health. To date, there is no specific treatment or vaccines against coronaviruses. To prevent the infection and stop the pandemic, the research and development of effective SARS-CoV-2 vaccines has become an urgent matter. It is worth mentioning that appropriate adjuvants could enhance the strength and speed of the immune responses to vaccination. However, it takes time to customize different adjuvants with distinct targets (cellular or humoral immunity) and action intensity according to different antigens. In this review, we summarize the mechanism, advantages and disadvantages of adjuvants commonly used in licensed vaccines, as well as some novel adjuvants under development, hoping to provide information and increase the chances of success in developing effective SARS-CoV-2 vaccines in a short time frame.\",\"PeriodicalId\":7277,\"journal\":{\"name\":\"Advanced techniques in biology & medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advanced techniques in biology & medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35248/2379-1764.20.8.274\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced techniques in biology & medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2379-1764.20.8.274","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

由SARS-CoV-2感染引起的2019冠状病毒病(COVID-19)作为一种新兴传染病已在全球蔓延,对全球经济和公共卫生造成了非常严重的影响。迄今为止,还没有针对冠状病毒的特异性治疗方法或疫苗。为预防感染和遏制疫情大流行,研发有效的SARS-CoV-2疫苗已成为当务之急。值得一提的是,适当的佐剂可以提高免疫应答的强度和速度。然而,根据不同的抗原定制具有不同靶点(细胞免疫或体液免疫)和作用强度的佐剂需要时间。本文综述了已获批疫苗中常用佐剂的作用机制、优缺点,以及一些正在研发的新型佐剂,希望能为短时间内研制出有效的SARS-CoV-2疫苗提供信息和增加成功的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Adjuvant Option for Effective SARS-CoV-2 Vaccine
Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2 infection, has spread all over the world as an emerging infectious disease, causing a very serious impact on the global economy and public health. To date, there is no specific treatment or vaccines against coronaviruses. To prevent the infection and stop the pandemic, the research and development of effective SARS-CoV-2 vaccines has become an urgent matter. It is worth mentioning that appropriate adjuvants could enhance the strength and speed of the immune responses to vaccination. However, it takes time to customize different adjuvants with distinct targets (cellular or humoral immunity) and action intensity according to different antigens. In this review, we summarize the mechanism, advantages and disadvantages of adjuvants commonly used in licensed vaccines, as well as some novel adjuvants under development, hoping to provide information and increase the chances of success in developing effective SARS-CoV-2 vaccines in a short time frame.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Efficiency of Transpiration in Plants Clinical, Laboratory Data and Outcomes of 17 Iranian Citrullinemia Type1 Patients: Identification of Five Novel ASS1 Gene Mutations Mutation Detection via CRISPRCas9 Micro-fluid Chip DNA Extraction by the Utilization of Phenol Chloroform Assessment on CORONA Drugs
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1